Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 62674

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 19, 2012
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Abbott Laboratories

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-4552-90.

D-1694-2012
Recall number
D-1694-2012
Initiated
July 19, 2012
Classification
Class II
Status
Terminated
Recalling firm
Abbott Laboratories
Quantity
53,448 Bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Code information

18265A8, Exp 09/20/2013

Distribution pattern

Nationwide

drug · product 2 of 3

Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.

D-1695-2012
Recall number
D-1695-2012
Initiated
July 19, 2012
Classification
Class II
Status
Terminated
Recalling firm
Abbott Laboratories
Quantity
42,596 Bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Code information

Lot: 18353A8, Exp 08/31/2013

Distribution pattern

Nationwide

drug · product 3 of 3

Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90

D-1696-2012
Recall number
D-1696-2012
Initiated
July 19, 2012
Classification
Class II
Status
Terminated
Recalling firm
Abbott Laboratories
Quantity
40,464 Bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Code information

Lot: 18355A8, Exp. 09/26/13

Distribution pattern

Nationwide

Field note

Send feedback

We'll only use this to respond to your feedback.